Skip to main content
Clinical Trials/NL-OMON40205
NL-OMON40205
Completed
Not Applicable

Metabolic phenotyping of individuals with abdominal obesity and high levels of hepatic fat before and after dietary interventions - Belly Fat Study

Wageningen Universiteit0 sites110 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
algehele gezondheid, metabole gezondheid
Sponsor
Wageningen Universiteit
Enrollment
110
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 40\-70y at the time of recruitment
  • BMI \>27kg/m2 or waist circumference \>102cm (males) or \>88cm (females)

Exclusion Criteria

  • Hb levels \<8\.4 mmol/L
  • Diabetic (normoglycemic according to WHO criteria (OGTT, fasting blood glucose\< 7 mmol/L, after 2 hr \<11\.1 mmol/L)
  • Daily intake of alcohol of \>30g (men) or \>20g (women)
  • Tobacco smoker
  • Abuse of drugs
  • Any medical conditions or (metal) devices interfering with or posing a risk for the participant in 1H\-MRS/MRI scanning (e.g. claustrophobia, pace maker, surgical screws/pins, artificial joints or heart valves, etc.)
  • Diagnosed with any long\-term medical condition (i.e. cardiovascular disease, gastrointestinal disease, renal dysfunction)
  • Use of medications known to interfere with glucose or lipid homeostasis (i.e. corticosteroids)
  • Allergic to fish oil or unwilling to consume fish oil supplements
  • Unwilling to comply with dietary guidelines

Outcomes

Primary Outcomes

Not specified

Similar Trials